TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Evaluate response rate of Docetaxel in combination with Carboplatin or Cisplatin as first
line chemotherapy in epithelial ovarian cancer. Assess the progression free survival,
tolerance, duration of response and survival in the same patient population.